(Total Views: 768)
Posted On: 04/29/2020 7:16:32 PM
Post# of 156873
"Under the agreement between Gilead and U.S. Army Medical Materiel Development Activity, remdesivir will be provided to the Defense Department at no cost."
https://www.militarytimes.com/news/your-milit...treatment/
That article popped up a few days after CytoDyn's conference call with these 2 items on top of the list for discussion.
Bruce Patterson, M.D., chief executive officer and founder of IncellDx, a diagnostic partner and advisor to CytoDyn, will provide a detailed explanation of the mechanism of action for treating coronavirus with leronlimab
Filing of an IND and Phase 2 clinical trial protocol with the FDA for the treatment of coronavirus with leronlimab in the U.S.
Maybe Gilead knew it was screwed if it didn't start throwing favors.
https://www.militarytimes.com/news/your-milit...treatment/
That article popped up a few days after CytoDyn's conference call with these 2 items on top of the list for discussion.
Bruce Patterson, M.D., chief executive officer and founder of IncellDx, a diagnostic partner and advisor to CytoDyn, will provide a detailed explanation of the mechanism of action for treating coronavirus with leronlimab
Filing of an IND and Phase 2 clinical trial protocol with the FDA for the treatment of coronavirus with leronlimab in the U.S.
Maybe Gilead knew it was screwed if it didn't start throwing favors.
(1)
(0)
